Hippocampal Subfields Segmentation Summit
Hippocampal Subfields Segmentation Summit
批准号:
10608845
负责人:
VALERIE A CARR
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-02-01 至 2024-01-31
关键词:
AdoptedAgeAgingAlzheimer&aposs DiseaseAnatomyAreaAutopsyAwardClinicalClinical ResearchConsensusData SetDedicationsDementiaDevelopmentDifferential DiagnosisDiseaseDissectionEarly DiagnosisEducational workshopEpilepsyFundingGerman populationGroup MeetingsHeadHealthHippocampusHistologicHistologyHumanImaging TechniquesInstitutionInternationalJointsKnowledgeLabelLocationMagnetic Resonance ImagingMeasurementMeasuresMedialMental DepressionMental disordersMethodologyModernizationNational Institute of Neurological Disorders and StrokeNeuroanatomyNeurodegenerative DisordersPathologyPopulationProcessProtocols documentationReproducibilityResearchResearch PersonnelResolutionResourcesSchizophreniaScientistSeriesSpecimenStructureTailTemporal LobeTerminologyTestingTrainingclinical translationdesignexperiencefeasibility testinghistological specimensimprovedin vivoinnovationinterestlecturesmeetingsmembernervous system disorderneuroimagingnovelprogramsprotocol developmentsymposiumvirtualworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The hippocampus and surrounding medial temporal lobe (MTL) cortices are composed of several distinct
subregions that show differential vulnerability in aging and disease. In vivo measurement of these regions via
magnetic resonance imaging (MRI) is required for modern clinical research, and improving their measurement
may allow early detection and sensitive tracking of incipient pathology as well as facilitate differential diagnosis
of uncertain clinical presentation. Due to a lack of precise and sensitive measurement, the manner in which
MTL subregions change in aging, Alzheimer's disease (AD), and other neurological and psychiatric disorders is
uncertain. Discrepancies in how MTL subregions are segmented by different research groups further impedes
clinical translation of key research findings. The solution to this issue is to develop a reliable, validated,
harmonized protocol for segmentation of MTL subregions that can be applied to populations of variable age
and health, an initiative that was launched in 2013 by the Hippocampal Subfields Group (HSG). The HSG is
the only working group of its kind and includes over 200 scientists actively segmenting the human MTL. Our
primary deliverable will be a gold-standard, valid, and highly reliable MRI segmentation protocol that can be
broadly adopted and applied to various populations, enabling direct comparison of results across researchers.
Formal development of the protocol first began in 2015, before dedicated funding was available, when we
developed a segmentation protocol for subfields within the hippocampal body. In 2016-17, with funding from
the EU Joint Programme on Neurodegenerative Disease, we held three meetings during which we developed a
protocol for the hippocampal head. We are currently developing a protocol for the hippocampal tail, an effort
begun during a meeting in 2018 sponsored in part by the German Center for Neuro-degenerative Diseases.
We anticipate that the head, body, and tail protocol will be completed in 2023, after which we propose to host
a two-part meeting that will enable us to expand our protocol to include MTL cortical subregions
(entorhinal, perirhinal, and parahippocampal cortices). Given the importance of creating a harmonized
protocol that is both reliable and valid, this protocol must reflect the known anatomy of the human MTL. The
first half of the proposed meeting will therefore involve a series of lectures regarding MTL neuroanatomy and
histology, as well as hands-on dissection activities using human MTL specimens. This unique opportunity will
facilitate the second portion of the meeting, in which we propose to utilize labeled histology from HSG
neuroanatomists and the hands-on knowledge gained from the first portion of the meeting to (a) develop a draft
segmentation protocol for MRI, and (b) conduct an initial feasibility test by applying each segmentation rule to
publicly available MRI data sets collected from multiple ages and pathologies. The completed harmonized
protocol will reduce methodological discrepancies across research group and enhance in vivo clinical research
progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pattern Separation and Generalization in the Hippocampus
-
批准号:7912765
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2010
-
负责人:VALERIE A CARR
-
依托单位:
Pattern Separation and Generalization in the Hippocampus
-
批准号:8077430
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2010
-
负责人:VALERIE A CARR
-
依托单位:
Pattern Separation and Generalization in the Hippocampus
-
批准号:8265706
-
项目类别:
-
资助金额:$5.57万
-
财政年份:2010
-
负责人:VALERIE A CARR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: